Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

4.1K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
4.1K
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

1.2K
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

977
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
977
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.1K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

493
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
493
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

620
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
620

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug interaction between maribavir and rifampin: a case report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

A three-year randomized, double-blind, placebo-controlled study of lanreotide in stage 2/3 autosomal dominant polycystic kidney disease.

Kidney international·2026
Same author

Outcomes and Validation of Histopathological Scores in Pediatric ANCA-vasculitis.

Kidney international reports·2026
Same author

Thrombotic Microangiopathy, Cryoglobulinemia, and Acute Kidney Injury in Patients With Monoclonal Gammopathy: A Case Series.

American journal of hematology·2026
Same author

Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.

Kidney international reports·2026
Same author

Immune Profiling Identifies High-Risk Neutrophil-Rich Subtype in Checkpoint Inhibitor Nephritis.

Kidney international reports·2026
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Related Experiment Video

Updated: Jan 28, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.5K

[Acute interstitial nephritis].

Alexandre Karras1

  • 1Service de néphrologie, hôpital européen Georges-Pompidou, AP-HP, faculté de médecine Paris-Descartes, Paris, France.

La Revue Du Praticien
|February 26, 2019
PubMed
Summary
This summary is machine-generated.

Acute interstitial nephritis, a common cause of acute kidney injury, involves inflammatory cell infiltration of the kidneys. Treatment depends on the cause and may include corticosteroids or other targeted therapies.

Keywords:
acute interstitial nephritisacute kidney injory

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles
08:50

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Published on: February 7, 2025

1.6K

Related Experiment Videos

Last Updated: Jan 28, 2026

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

1.5K
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.8K
Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles
08:50

Enzymatic Isolation of Skeletal Muscle Interstitial Extracellular Vesicles

Published on: February 7, 2025

1.6K

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Acute interstitial nephritis (AIN) accounts for 10-30% of biopsy-proven acute kidney injury.
  • AIN is characterized by inflammatory cell infiltration, edema, tubulopathy, and potential fibrosis.
  • Causes include drug toxicity, infections, autoimmune diseases, and malignancy.

Purpose of the Study:

  • To summarize the key aspects of acute interstitial nephritis.
  • To highlight the diverse etiologies and clinical presentation of AIN.
  • To outline the general treatment strategies for AIN.

Main Methods:

  • Review of existing literature on acute interstitial nephritis.
  • Analysis of characteristic pathological findings in AIN.
  • Compilation of common causes and clinical features.

Main Results:

  • AIN presents with interstitial inflammation, edema, and tubular damage.
  • Common triggers include medications (direct toxicity or allergic reactions), infections, and autoimmune conditions.
  • Clinical signs often include aseptic leukocyturia and mild proteinuria without albuminuria.

Conclusions:

  • Acute interstitial nephritis is a significant contributor to acute kidney injury.
  • Prompt diagnosis and cause-specific treatment are crucial for managing AIN.
  • Treatment modalities vary widely, including drug withdrawal, corticosteroids, and chemotherapy.